Effect of Comorbidities and Risk Factors on Outcomes and Ivabradine's Effects in Patients With Chronic Systolic Heart Failure in the SHIFT Trial

被引：0
|
作者：
Boehm, Michael [1 ]
Borer, Jeffrey S. [2 ]
Ford, Ian [3 ]
Komajda, Michel [4 ]
Robertson, Michele [3 ]
Tavazzi, Luigi [5 ]
Swedberg, Karl [6 ]
机构：
[1] Univ Saarlandes Kliniken, Homburg, Germany
[2] Suny Downstate Med Ctr, New York, NY USA
[3] Univ Glasgow, Glasgow, Lanark, Scotland
[4] Univ Paris 06, Paris, France
[5] Maria Cecilia Hosp, Cotignola, Italy
[6] Univ Gothenburg, Gothenburg, Sweden
来源：
JOURNAL OF CARDIAC FAILURE | 2015年 / 21卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
090
引用
收藏
页码：S46 / S46
页数：1
相关论文
共 50 条
  • [21] Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study
    Boehm, Michael
    Borer, Jeffrey
    Ford, Ian
    Gonzalez-Juanatey, Jose R.
    Komajda, Michel
    Lopez-Sendon, Jose
    Reil, Jan-Christian
    Swedberg, Karl
    Tavazzi, Luigi
    CLINICAL RESEARCH IN CARDIOLOGY, 2013, 102 (01) : 11 - 22
  • [22] Efficacy of ivabradine in heart failure patients with a high-risk profile (analysis from the SHIFT trial)
    Abdin, Amr
    Komajda, Michel S.
    Borer, Jeffrey
    Ford, Ian
    Tavazzi, Luigi
    Batailler, Cecile
    Swedberg, Karl
    Rosano, Giuseppe M. C.
    Mahfoud, Felix
    Boehm, Michael
    ESC HEART FAILURE, 2023, 10 (05): : 2895 - 2902
  • [23] Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study
    Michael Böhm
    Jeffrey Borer
    Ian Ford
    Jose R. Gonzalez-Juanatey
    Michel Komajda
    Jose Lopez-Sendon
    Jan-Christian Reil
    Karl Swedberg
    Luigi Tavazzi
    Clinical Research in Cardiology, 2013, 102 : 11 - 22
  • [24] The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT
    Voors, A. A.
    Van Veldhuisen, D. J.
    Robertson, M.
    Ford, I.
    Borer, J.
    Boehm, M.
    Komajda, M.
    Swedberg, K.
    Tavazzi, L.
    EUROPEAN HEART JOURNAL, 2013, 34 : 162 - 163
  • [25] The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT
    Voors, Adriaan A.
    van Veldhuisen, Dirk J.
    Robertson, Michele
    Ford, Ian
    Borer, Jeffrey S.
    Boehm, Michael
    Komajda, Michel
    Swedberg, Karl
    Tavazzi, Luigi
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 (04) : 426 - 434
  • [26] Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
    Koltowski, Lukasz
    KARDIOLOGIA POLSKA, 2010, 68 (11) : 1299 - 1302
  • [27] Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
    Swedberg, Karl
    Komajda, Michel
    Boehm, Michael
    Borer, Jeffrey S.
    Ford, Ian
    Dubost-Brama, Ariane
    Lerebours, Guy
    Tavazzi, Luigi
    LANCET, 2010, 376 (9744): : 875 - 885
  • [28] THE PREVALENCE AND CORRELATED RISK FACTORS OF ARRHYTHMIA IN PATIENTS WITH CHRONIC SYSTOLIC HEART FAILURE
    Yu Shengbo
    HEART, 2011, 97
  • [29] Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
    Swedberg, Karl
    Komajda, Michel
    Boehm, Michael
    Borer, Jeffey S.
    Ford, Ian
    Dubost-Brama, Ariane
    Lerebours, Guy
    Tavazzi, Luigi
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2010, 29 (7-8) : 1273 - 1273
  • [30] The effects of ivabradine on left atrial electromechanical function in patients with systolic heart failure
    Ozturk, Serkan
    Ozturk, Selcuk
    Erdem, Fatma Hizal
    Erdem, Alim
    Ayhan, Selim
    Donmez, Ibrahim
    Yazici, Mehmet
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2016, 46 (03) : 253 - 258
12345